Biontech Se Sponsored Adr Stock News

BioNTech and its Covid vaccine partner Pfizer Inc put plans into place months ago to ensure a new version of their shot could ship within 100 days if necessary

Ministry expects the delivery of children vaccines by Pfizer/BionTech by the end of 2021.

Fears about the Omicron variant of Covid-19 rattled the world's financial markets Friday and early Monday morning. But shares of the major coronavirus vaccine makers were getting a boost from the late

FRANKFURT, Nov 26 (Reuters) - BioNTech SE said on Friday it expects more data on a worrying new coronavirus variant detected in South Africa within two weeks to help determine whether its vaccine produced with partner Pfizer Inc would have to be reworked.

The German biotech, which makes COVID-19 vaccines with Pfizer, said Monday it doesn't want to "waste any time" and is working on an "adapted" vaccine.

Will the vaccines stop the Omicron variant of the coronavirus, the New York Times asks. The new version raises new concerns, because if it turns out that the existing vaccines do not affect it, they will have to be modified, the American publication notes. Amid disconnections from South Africa and fears of a new global wave of coronavirus over the weekend, scientists began frantic work to collect data on the new variant of Coronvirus Omicron, its features and, above all, how effective the vaccines will be against him. The initial information paints a vague picture. It is possible that the variant is more easily transmitted and easier to avoid the body''s immune reactions, both in the case of vaccination and in natural infection, compared to previous variants of the virus, experts said. Vaccines may continue to provide adequate protection in terms of preventing severe forms of covid and death, but booster doses may be needed to ensure protection for most people. Manufacturers of the two most effective vaccines, Pfizer / Biontech and Moderna, are preparing to modify their preparations if necessary, the New York Times points out.

Britain has announced that it will convene an emergency meeting of G-7 health ministers tomorrow to discuss developments in the new coronavirus variant, Omicron, Reuters reported. The British government announced new measures yesterday in an attempt to slow down the spread of the option. The rules for those arriving in the country have been tightened, and wearing masks is mandatory in retail outlets and public transport in England. Some students will also have to wear masks in the common areas of the schools. European Commission President Ursula von der Leyen called for precautionary measures and swift action, DPA reported. "We take the Omicron option very seriously and we know we are racing against time," Von der Layen said during a visit to Latvia. She added that not everything is known yet, as scientists and manufacturers will need two to three weeks to get a full idea of the strength of the option. The general rule is: "Hope for the best, prepare for the worst," she said. She said the EU was "safe" when it came to vaccines.

The following article, Yet another jab: Pfizer and BioNTech say vaccine for new Omicron strain can be ready in 100 days , was first published on BizPac Review . Get the latest BPR news delivered free to your inbox daily. SIGN UP HERE The discovery of yet another COVID variant could be a boon to pharmaceutical companies [] Continue reading Yet another jab: Pfizer and BioNTech say vaccine for new Omicron strain can be ready in 100 days

World Medical Association Chair Demands National Lockdowns, Compulsory Jabs, Fears COVID "Variant As Dangerous As Ebola" The Omicron variant was identified six days ago, initially in Botswana. Infections have been detected in South Africa, Israel, Hong Kong, Belgium, and the UK. So far, the spreading of the heavily mutated variant of the Coronavirus has resulted in a stark warning from one top medical official. On Saturday, Frank Ulrich Montgomery, chairman of the global physicians'' society of the World Medical Association (WMA), told German reporters that he believes Omicron could become as dangerous as the Ebola virus. Montgomery said, "the fastest and best thing to do is contact restrictions. We must avoid any form of crowd in the coming weeks . We should therefore close the Christmas markets nationwide." He emphasized the importance of not giving the virus "a chance to mutate by preventing every possible infection." "The new South African variant is a good example of this. We don''t yet know anything about its dangerousness - but it seems to be spreading rapidly.

New Delhi: In South Africa, Omicron, a new corona infection subtype, has developed. It has sparked fear throughout the world. According to the information so far, the new variant is also capable of beating the corona vaccination. Many scientists have also warned that if new corona variations emerge, the vaccination would need to be modified as well. With the emergence of the omicron, efforts to develop a vaccine for it have accelerated. Novavax, a firm based in the United States, said that it has begun developing a vaccine to combat new strains. The vaccine will also be available for testing and manufacture in the coming weeks, according to the firm. The business claims to be developing a spike protein that would boost immunity against the new variety B.1.1.529. This week, a novel Corona B.1.1529 strain was discovered in South Africa. The World Health Organization (WHO) labelled it as "alarming" on Friday, using the term "variant of concern" to describe it. ''Omicron'' is the name given to it.

Highlights Omicron has made its way to the UK, Germany, Italy, Israel, Belgium and Hong Kong. WHO has classified the new infection as a variant of concern. Omicron or B.1.1.529 strain was first confirmed from a sample collected on 9 November 2021 and was first reported to WHO on 24 November 2021. The new, more infectious variant, Omicron, has made its way to Europe, Australia after circulation across Southern African countries for most of November. The UK, Germany, Italy, Israel, Belgium and Hong Kong reported the first cases on Saturday, while Australia reported the first confirmed infection on Sunday. The arrival of the new variant has been responded to by prompt investigations by the vaccine makers, including Pfizer, BioNTech, Moderna, Johnson & Johnson and AstraZeneca. Must Read: US markets slip on new covid variant fears The onset of the new infections has led the governments to take strict measures to contain or prevent the virus strain from spreading. The UK has tightened its mask-wearing rules and accelerated its testing of international arrivals.

A new, potentially more contagious variant of the coronavirus is already circulating in Europe. A number of countries have banned the entry of passengers from southern Africa, where the Omicron variant was found, in the past two days. Britain, Germany, Italy and the Czech Republic yesterday identified the first cases of people infected with this variant and announced new measures to control the infection. Fears of the new variant and the potential for it to be more resistant to the protection provided by vaccines are raising concerns that the pandemic and related lockdowns and restrictions may last longer than expected. Nearly two years after the start of the pandemic, which claimed the lives of more than 5 million people globally, countries around the world are on the alert. On Friday, a number of countries banned flights from South Africa and neighboring countries to allow time to assess whether this option is more contagious than the currently dominant Delta option. The Republic of South Africa regretted the closure of the borders of dozens of countries for its citizens and travelers and said that the discovery of the new version of Omicron coronavirus thanks to the work of South African scientists should not be "punished" in this way. "This latest series of travel bans is actually punishing South Africa for its progress in genomic sequencing and its ability to discover new variants more quickly.

The new potentially more contagious omicron variant of the coronavirus popped up in more European countries on Saturday, just days after being identified in South Africa, leaving governments around the world scrambling to stop the spread. The U.K. on Saturday tightened its rules on mask-wearing and on testing of international arrivals after finding two cases. New cases were confirmed Saturday in Germany and Italy, with Belgium, Israel and Hong Kong also reporting that the variant has been found in travellers. In the U.S., Dr. Anthony Fauci, the governments top infectious diseases expert, said he would not be surprised if the omicron variant was already in the United States, too. We have not detected it yet, but when you have a virus that is showing this degree of transmissibility it almost invariably is ultimately going to go essentially all over, Fauci said on NBC television. Because of fears that the new variant has the potential to be more resistant to the protection offered by vaccines, there are growing concerns around the world that the pandemic and associated lockdown restrictions will persist for far longer than hoped.

A new strain of COVID-19 first discovered in South Africa was declared a variant of concern by the World Health Organization on Friday. Here''s how the pharmaceutical industry plans to address the latest coronavirus curve ball. Vaccine makers are already pivoting their efforts to combat the new variant: testing higher doses of booster shots, designing new boosters that anticipate strain mutations, and developing omicron-specific boosters. In a statement sent to NPR, Moderna said it has been working on a comprehensive strategy to predict variants of concern since the beginning of 2021. One approach is to double the current booster from 50 to 100 micrograms. Secondly, the vaccine maker has been studying two booster vaccines that are designed to anticipate mutations like those found in the omicron variant. The company also said it will ramp up efforts to make a booster candidate that specifically targets omicron. "From the beginning, we have said that as we seek to defeat the pandemic, it is imperative that we are proactive as the virus evolves," said Moderna CEO Stéphane Bancel. "The mutations in the Omicron variant are concerning and for several days, we have been moving as fast as possible to execute our strategy to address this variant." Pfizer and BioNTech told Reuters that it expects more data about the omicron variant to be collected within two weeks.